938 related articles for article (PubMed ID: 22426019)
21. Protective effects of clioquinol on human neuronal-like cells: a new formulation of clioquinol-loaded PLGA microspheres for Alzheimer's disease.
Barcia E; Salama A; Fernández-Carballido A; Negro S
J Drug Target; 2011 Sep; 19(8):637-46. PubMed ID: 20945972
[TBL] [Abstract][Full Text] [Related]
22. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
[TBL] [Abstract][Full Text] [Related]
23.
Zhang L; Yang S; Wong LR; Xie H; Ho PC
Mol Pharm; 2020 Nov; 17(11):4256-4269. PubMed ID: 33084343
[TBL] [Abstract][Full Text] [Related]
24. Intracellular drug release from curcumin-loaded PLGA nanoparticles induces G2/M block in breast cancer cells.
Verderio P; Bonetti P; Colombo M; Pandolfi L; Prosperi D
Biomacromolecules; 2013 Mar; 14(3):672-82. PubMed ID: 23350530
[TBL] [Abstract][Full Text] [Related]
25. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
[TBL] [Abstract][Full Text] [Related]
26. Graft copolymer nanoparticles with pH and reduction dual-induced disassemblable property for enhanced intracellular curcumin release.
Zhao J; Liu J; Xu S; Zhou J; Han S; Deng L; Zhang J; Liu J; Meng A; Dong A
ACS Appl Mater Interfaces; 2013 Dec; 5(24):13216-26. PubMed ID: 24313273
[TBL] [Abstract][Full Text] [Related]
27. Nickel oxide nanoparticles induce cytotoxicity, oxidative stress and apoptosis in cultured human cells that is abrogated by the dietary antioxidant curcumin.
Siddiqui MA; Ahamed M; Ahmad J; Majeed Khan MA; Musarrat J; Al-Khedhairy AA; Alrokayan SA
Food Chem Toxicol; 2012 Mar; 50(3-4):641-7. PubMed ID: 22273695
[TBL] [Abstract][Full Text] [Related]
28. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
[TBL] [Abstract][Full Text] [Related]
30. Nanocapsulated curcumin: oral chemopreventive formulation against diethylnitrosamine induced hepatocellular carcinoma in rat.
Ghosh D; Choudhury ST; Ghosh S; Mandal AK; Sarkar S; Ghosh A; Saha KD; Das N
Chem Biol Interact; 2012 Feb; 195(3):206-14. PubMed ID: 22197969
[TBL] [Abstract][Full Text] [Related]
31. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo.
Anand P; Nair HB; Sung B; Kunnumakkara AB; Yadav VR; Tekmal RR; Aggarwal BB
Biochem Pharmacol; 2010 Feb; 79(3):330-8. PubMed ID: 19735646
[TBL] [Abstract][Full Text] [Related]
32. Effect of preparation conditions on the size and encapsulation properties of mPEG-PLGA nanoparticles simultaneously loaded with vincristine sulfate and curcumin.
Wang H; Jia Y; Hu W; Jiang H; Zhang J; Zhang L
Pharm Dev Technol; 2013; 18(3):694-700. PubMed ID: 22676257
[TBL] [Abstract][Full Text] [Related]
33. Curcumin-loaded nanoparticles enhance apoptotic cell death of U2OS human osteosarcoma cells through the Akt-Bad signaling pathway.
Peng SF; Lee CY; Hour MJ; Tsai SC; Kuo DH; Chen FA; Shieh PC; Yang JS
Int J Oncol; 2014 Jan; 44(1):238-46. PubMed ID: 24247158
[TBL] [Abstract][Full Text] [Related]
34. Enhanced Therapeutic Potential of Nano-Curcumin Against Subarachnoid Hemorrhage-Induced Blood-Brain Barrier Disruption Through Inhibition of Inflammatory Response and Oxidative Stress.
Zhang ZY; Jiang M; Fang J; Yang MF; Zhang S; Yin YX; Li DW; Mao LL; Fu XY; Hou YJ; Fu XT; Fan CD; Sun BL
Mol Neurobiol; 2017 Jan; 54(1):1-14. PubMed ID: 26708209
[TBL] [Abstract][Full Text] [Related]
35. Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles.
Feng R; Song Z; Zhai G
Int J Nanomedicine; 2012; 7():4089-98. PubMed ID: 22888245
[TBL] [Abstract][Full Text] [Related]
36. Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release.
Chhabra R; Grabrucker AM; Veratti P; Belletti D; Boeckers TM; Vandelli MA; Forni F; Tosi G; Ruozi B
Int J Pharm; 2014 Aug; 471(1-2):349-57. PubMed ID: 24882034
[TBL] [Abstract][Full Text] [Related]
37. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.
Joshi SA; Chavhan SS; Sawant KK
Eur J Pharm Biopharm; 2010 Oct; 76(2):189-99. PubMed ID: 20637869
[TBL] [Abstract][Full Text] [Related]
38. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting.
Md S; Ali M; Baboota S; Sahni JK; Bhatnagar A; Ali J
Drug Dev Ind Pharm; 2014 Feb; 40(2):278-87. PubMed ID: 23369094
[TBL] [Abstract][Full Text] [Related]
39. Effect of polymer architecture on curcumin encapsulation and release from PEGylated polymer nanoparticles: Toward a drug delivery nano-platform to the CNS.
Rabanel JM; Faivre J; Paka GD; Ramassamy C; Hildgen P; Banquy X
Eur J Pharm Biopharm; 2015 Oct; 96():409-20. PubMed ID: 26409200
[TBL] [Abstract][Full Text] [Related]
40. Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo.
Kang BK; Chon SK; Kim SH; Jeong SY; Kim MS; Cho SH; Lee HB; Khang G
Int J Pharm; 2004 Nov; 286(1-2):147-56. PubMed ID: 15501011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
